The changes in GIR correlated negatively with the changes in weight, BMI, body fat mass, and HbA1c before and after SG (rs=-0.665, -0.709, -0.699, -0.678, respectively)
71 Injections may sometimes cause minor irritation, redness, or itching at the injection site
This falls well below the 10% safety threshold recommended for medications taken while breastfeeding, but again, results are only specific to that study
The specific dose ranges and escalation steps differ: Tirzepatide Dosing (FDA-Approved) Retatrutide Dosing (Clinical Trial Protocol) Use our retatrutide dosing calculator or tirzepatide dosing calculator to plan your specific titration schedule
Sood expects them to show a positive outcome of this class of drugs as a whole